References |
1 |
Amiodarone Hydrochloride was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration.
|
2 |
A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor. Drug Metab Dispos. 2000 Nov;28(11):1303-10.
|
3 |
Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy. J Cardiovasc Pharmacol Ther. 2001 Oct;6(4):363-7.
|
4 |
Functional characterization of five novel CYP2C8 variants, G171S, R186X, R186G, K247R, and K383N, found in a Japanese population. Drug Metab Dispos. 2005 May;33(5):630-6.
|
5 |
Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
|
6 |
Potentially significant drug interactions of class III antiarrhythmic drugs. Drug Saf. 2003;26(6):421-38.
|
7 |
The metabolism of amiodarone by various CYP isoenzymes of human and rat, and the inhibitory influence of ketoconazole. J Pharm Pharm Sci. 2008;11(1):147-59.
|
8 |
Pharmacology and pharmacokinetics of amiodarone
|
9 |
Determination of the cardiac drug amiodarone and its N-desethyl metabolite in sludge samples
|
10 |
Amiodarone and concurrent antiretroviral therapy: a case report and review of the literature
|